HIV-1 Vpu and SARS-CoV-2 ORF3a proteins disrupt STING-mediated activation of antiviral NF-κB signaling
Science Signaling · 2025
DOI: 10.1126/scisignal.add6593 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Signaling, 2025. Verfasst von Yajuan Rui und 9 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), Second Affiliated Hospital, Zhejiang U…. Hauptthemen laut MEDLINE: NF-kappa B, Membrane Proteins, Viral Regulatory and Accessory Proteins, Signal Transduction. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben.
Abstract (Originalsprache)
Activation of the stimulator of interferon genes (STING) pathway by cytosolic DNA leads to the activation of the transcription factors interferon regulatory factor 3 (IRF3) and nuclear factor κB (NF-κB). Although many viruses produce proteins that inhibit IRF3-dependent antiviral responses, some viruses produce proteins that inhibit STING-induced NF-κB activation without blocking IRF3 activation. Here, we found that STING-activated, NF-κB–dependent, and IRF3-independent innate immunity inhibited the replication of the DNA virus herpes simplex virus type 1 (HSV-1), the RNA virus coxsackievirus A16 (CV-A16), and the retrovirus HIV-1. The HIV-1 nonstructural protein Vpu bound to STING and prevented it from interacting with the upstream NF-κB pathway kinase inhibitor of NF-κB subunit β (IKKβ), thus blocking NF-κB signaling. This function of Vpu was conserved among Vpu proteins from diverse HIV-1 and simian immunodeficiency virus strains and was distinct from its action in disrupting other host antiviral pathways. Furthermore, the ORF3a protein from the coronavirus SARS-CoV-2 also promoted viral replication by interacting with STING and blocking STING-induced activity of NF-κB but not of IRF3. These findings demonstrate that diverse viral proteins have convergently evolved to selectively inhibit NF-κB–mediated innate immunity downstream of STING activation, suggesting that targeting this pathway may represent a promising antiviral strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education), Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, China.
- Cancer Center of Zhejiang University, Hangzhou, Zhejiang 310000, China.
- Department of Respiratory Disease, Thoracic Disease Center, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310003, China.
- School of Life Science, Jilin University, Changchun 130012, China.
- Key Laboratory of Organ Regeneration and Transplantation of Ministry of Education, Institute of Translational Medicine and Institute of Virology and AIDS Research, First Hospital, Jilin University, Changchun, Jilin 1300…
ORCID-Profile: Yajuan Rui, Si Shen, Yanpu Wang, Wei Wei, Jiaming Su, Xiao-Fang Yu
Zitieren
APA
Rui, Y., Shen, S., Wang, Y., Cheng, L., Chen, S., Hu, Y., Cai, Y., Wei, W., Su, J., & Yu, X. F. (2025). HIV-1 Vpu and SARS-CoV-2 ORF3a proteins disrupt STING-mediated activation of antiviral NF-κB signaling. Science Signaling. https://doi.org/10.1126/scisignal.add6593
Vancouver
Rui Y, Shen S, Wang Y, Cheng L, Chen S, Hu Y, et al. HIV-1 Vpu and SARS-CoV-2 ORF3a proteins disrupt STING-mediated activation of antiviral NF-κB signaling. Science Signaling. 2025. doi:10.1126/scisignal.add6593
BibTeX
@article{Rui2025,
author = {Rui, Yajuan and Shen, Si and Wang, Yanpu and Cheng, Leyi and Chen, Shiqi and Hu, Ying and Cai, Yong and Wei, Wei and Su, Jiaming and Yu, Xiao-Fang},
title = {HIV-1 Vpu and SARS-CoV-2 ORF3a proteins disrupt STING-mediated activation of antiviral NF-κB signaling},
journal = {Science Signaling},
year = {2025},
doi = {10.1126/scisignal.add6593}
}
EUVIMED